Key points are not available for this paper at this time.
Background:There is a lack of accurate models to predict amyotrophic lateral sclerosis (ALS) disease course and outcomes.As a result, risk assessment and counseling, the timing of interventions, and their stratification in clinical trials are difficult.This study aimed to evaluate the association between symptoms at presentation and mortality. Material/Methods:A single veterans hospital reviewed the electronic records of 105 veterans with ALS who were periodically followed in our ALS clinic between 2010 and 2021.A survival decision tree (£3 or >3 years) was generated based on the statistical median survival of our data.The variables known to influence survival when alive were compared to patients who died. Results:The (mean±SD) age at onset was 62±11 years, M/F ratio 101: 4, and 90% were non-Hispanic whites.The initial score for the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R) was 31±8.3.Dysarthria and shortness of breath (SOB) were present on initial presentation in 52 (49.5%) and 32 (30.5%) patients, respectively.Deaths occurred in 80 (76.2%) patients during the study period.The main cause of death was respiratory disease (failure and pneumonia, n=43 53.75%).Patients survived for >3 years on initial presentation with normal respiration and speech, compared to £3 years of survival in patients with dysarthria and SOB, irrespective of age. Conclusions:This study suggests that for veterans with ALS, the main predictors of shorter survival were respiratory status and speech disorder on initial presentation to the clinic.
Rabadi et al. (Thu,) studied this question.